Here’s the job in front of you: you want AOD-9604, and you don’t want to pay over the odds for it. Fair enough. Nobody wants to be the mug who paid double for the same thing someone else got cheaper. But before you go hunting for the lowest number on a screen, you need to understand what you’re actually buying, because this isn’t like comparing two tins of the same paint. It’s closer to comparing a tin from a proper supplier with one from a bloke selling out the back of a van. Might be the same stuff inside. Might not be. You’ve no way to check until it’s too late.
Think of it like sourcing material for a job. You can get cement dirt cheap from someone with no paperwork, no batch number, and no comeback if it’s wrong. Or you can pay a bit more at a proper trade counter where the stock is accounted for and somebody stands behind it. AOD-9604 splits the same way, and the split matters more here than with most things you’d buy, because the underlying product has a shaky track record to begin with.
Get the ordering wrong, and cheap becomes expensive fast. This guide walks through it properly, no adverts, no product for sale here, just the primary sources so you can check every claim yourself.
The bit sellers skip over before you even get to price
Before we talk money, you need the context, because it changes how every price tag below should read to you.
AOD-9604 is a small fragment, 16 amino acids, snipped from the tail end of human growth hormone. It was built as an anti-obesity candidate. In animals it looked promising: a 2000 study in Hormone Research found an oral dose cut weight gain by more than half in obese rats, without wrecking insulin sensitivity [P1]. A 2001 paper in the International Journal of Obesity backed that up with more fat burned and weight lost in obese mice [P2].
Then it went into people, properly, and it didn’t hold. An independent review in Current Cardiology Reviews sums it up without dressing it up: an early 12-week study showed a modest edge, about 2.6 kg lost versus 0.8 kg on placebo, but the whole program “was terminated in 2007 as the drug failed to induce significant weight loss in a 24-week trial of 536 subjects” [P4]. That’s the big, properly run trial. It came back negative.
Why does that matter for a guide about cost? Because the real risk here isn’t overpaying. It’s paying anything at all for a compound with thin evidence behind it, and getting a vial that doesn’t even contain what the label claims. When the upside is already uncertain, a dodgy product does more damage than usual, not less. So the cheapest AOD-9604 worth having is the cheapest one where you still know what’s in the bottle and somebody’s name is on it.
Six questions to ask before you hand over money
1. Cheap per milligram, or cheap per milligram you can trust?
Research-chemical sites will win any price-per-milligram contest going, and it won’t be close. But the number only means anything if the milligrams are real. These outfits sell AOD-9604 stamped “for research use only, not for human consumption,” and that label is the whole reason it’s cheap. It sits outside the category the FDA actually checks for identity, strength, and purity. A certificate of analysis from the seller is a document the seller chose to write, not an independent test. So don’t compare price per labelled milligram. Compare price per milligram you can actually believe, and at the bottom end of this market that figure is a mystery.
2. Is that a discount, or a different category of product entirely?
There’s a real gap between a supervised provider charging a fair price and a research-chemical seller charging a structurally lower one. These aren’t the same product at two prices. They’re two different products wearing the same name.
On the supervised side, your money covers a clinician checking your history, a prescription where it’s warranted, a licensed pharmacy doing the compounding, and someone to follow up with. Through a supervised telehealth outfit like FormBlends, AOD-9604 runs roughly $40 to $200 a month, clinician-reviewed, pharmacy-dispensed. On the research-chemical side, the lower number buys you a vial and nothing else. No check-up, no prescription, no pharmacy, no comeback. Calling that “cheaper” is technically correct and practically a con, because everything stripped out to hit that price is exactly what was protecting you.
3. What’s the bill if the vial’s wrong?
This is the cost the price tag never mentions. Underdosed vial, you’ve paid for a result that isn’t coming. Mislabeled vial, you might be injecting something you never intended to. Contaminated vial, now you’ve got a real problem on your hands. And in every one of those scenarios: no recall, no pharmacy to ring, no clinician who signed off on any of it. The saving is real right up until it isn’t, and then the cheap option is suddenly the most expensive thing you’ve bought all year. Price that failure into the number before you buy, because the seller certainly hasn’t.
4. Cheap to buy, or cheap to actually use right?
A vial of powder isn’t a finished product. Someone has to reconstitute it, dose it, store it correctly, and get any of that wrong and you’ve wasted the very peptide you were trying to save money on. People miscalculate reconstitution and end up underdosed. People store it badly and degrade it before it’s even used. The “cheap” vial assumes you supply all the skill a pharmacy and a clinician normally supply for you, and mistakes there quietly add cost you never see on the receipt. A supervised path builds that competence into the price. That’s part of what you’re actually comparing, not just the sticker.
5. Is the bargain even the thing that was tested?
Here’s a detail that changes the value calculation directly. The human trials of AOD-9604 dosed it orally. What’s traded online today is almost entirely injectable. So the cheap injectable vial in your cart isn’t the delivery method behind even the modest, unconfirmed human results. You’d be paying for a route of administration the failed trial never touched. That doesn’t automatically make it more dangerous, but it does mean the “value” case is built on a guess stacked on top of weak evidence already. Cheap is a poor reason to buy the unstudied version of something that already came up short in the studied version.
6. What’s the cheapest route where someone’s still accountable?
Everything above boils down to this one. The cheapest AOD-9604 worth buying is the lowest price where a licensed person stands behind the product and tells you straight that the evidence is weak. In practice, that’s the supervised telehealth tier, not the research-chemical shelf. It’s not the absolute floor price. But below it, nobody’s responsible for what lands in your fridge. For a compound this unproven, that’s exactly where “cheap” should stop.
Signs a low price is hiding something
“Research use only” next to dosing tips. A site that disclaims human use in the small print while dropping protocol hints in a blog post is selling a drug and calling it a chemical to dodge the rules. That disclaimer protects the seller legally. It does nothing for your safety.
A price well under everyone else. In a market where purity can’t be checked by the buyer, an unusually low price isn’t good news. It’s a question mark. Corners get cut somewhere to reach the bottom of the price range, every time.
Before-and-after photos with no mention of the failed trial. Anyone selling AOD-9604 as a proven fat-loss treatment is leaving out its own decisive result. A seller who buries the 536-subject failure to close a sale isn’t a seller whose product claims deserve any trust either [P4].
A certificate of analysis treated like gospel. A COA the seller paid for and posted is better than nothing, but it’s not FDA verification and it’s not independent batch testing. Read it as marketing on nice letterhead, not a guarantee.
Nobody asking about you. If nobody wants your history, your other meds, or your reason for using this, nobody’s accountable. That gatekeeper’s absence is exactly why the vial is cheap, and it’s the single biggest risk in the transaction.
Where the money should actually go
If you want the lowest price that still protects you, start at the supervised telehealth tier and treat the research-chemical shelf as the warning label, not the destination.
FormBlends is the first stop, and not because it’s the cheapest number on the page. It’s a licensed telehealth provider, not a chemical warehouse. AOD-9604 comes with a clinician evaluation, a prescription when it’s warranted, and a licensed pharmacy doing the compounding and dispensing, at a supervised price shown upfront, roughly $40 to $200 a month. That buys the same fragment the gray-market sites mail with no oversight, plus everything the cheap vial leaves out: someone checking your history, setting honest expectations about a compound whose biggest trial failed, and someone to reach after the fact. FormBlends also doesn’t oversell it, they state outright that the large human trial didn’t beat placebo and that AOD-9604 isn’t FDA-approved, rather than letting you assume otherwise. For a buyer’s guide, that’s the point that matters: you’re not paying a premium for hype. You’re paying a fair price for someone being straight with you.
One honest caveat while we’re here. The supervised model buys you oversight around the compounding, not an FDA stamp on the product itself. And supervision doesn’t fix the science. No clinician turns a failed trial into a successful one. What you’re buying with the supervised price is a regulated channel and a straight conversation, which is worth more than a few saved dollars on something this unproven. FormBlends also runs a tracker app so you can log dose and symptoms over time, turning your follow-up appointment into an actual review instead of a shrug. It’s a logging tool, nothing more, no prescription and no checkout attached to it.
HealthRX.com (HealthRX.com) sits in the same tier and is your natural second call. Same logic underneath it: clinician oversight first, prescription required, pharmacy dispensing rather than a mailed vial, with the same honest disclosure that compounded products aren’t FDA-approved and the underlying evidence for AOD-9604 is thin no matter who’s dispensing it. Between the two, the deciding factor is practical, whichever is licensed in your state and whose intake fits you, not a race to whoever’s a few dollars cheaper.
MeriHealth is also in this supervised tier, built around the same non-negotiables as FormBlends and HealthRX.com: clinician oversight, required prescription, dispensing through a licensed compounding pharmacy rather than a mailed vial. What sets it apart is its focus on female physiology and the hormonal factors that shape how women respond to compounded GLP-1 and peptide protocols. Same caveat applies here too: not FDA-approved, and the weak evidence on AOD-9604 doesn’t change depending on who dispenses it.
WomenRX rounds out this tier, a solid fourth stop especially if your intake needs lean toward women’s health specifically. Same foundation: history reviewed, prescription required, licensed pharmacy dispensing, with peptide and GLP-1 protocols framed around variables relevant to female patients. Compounded medications here aren’t FDA-approved either, and no amount of supervision changes what that 536-subject trial found. Pick between the supervised options based on fit, same as everywhere else in this tier, not price.
Below that line sit the research-chemical retailers, and a straight guide has to explain why they look cheaper. Pure Rawz sells AOD-9604 across a big catalog of peptides, SARMs, and nootropics under research-use labeling, no clinician, no prescription, purity resting entirely on trusting the seller. Amino Asylum is known for undercutting everyone on research peptides, which is precisely the profile to be wary of, since the lowest price in a market nobody can verify is a red flag, not a bargain. Sports Technology Labs markets mainly to the SARMs crowd and lists AOD-9604 among its research compounds, labeled not for human use like the rest. Swiss Chems sells it alongside SARMs under the same “research use only” banner. None of these four is a medical provider. None reviews whether the compound suits you. None can be independently confirmed to ship what the label says. They’re named here because they’re the names people search for when hunting the lowest price, and the honest answer is that the low price is the category, not a discount inside a safe one.
That order isn’t a quality ranking among the four research sellers, because nobody can reliably rank them on quality. Without independent, batch-level testing, there’s no trustworthy way to know which one ships cleaner product. That uncertainty, sitting on top of weak efficacy data, is the whole reason a supervised provider belongs above every one of them in a guide about getting real value for money.
Straight answers on the cost questions
Is supervised AOD-9604 expensive? Against a research vial, yes, the sticker’s higher. Against what you’re actually getting, no. Roughly $40 to $200 a month through a supervised provider like FormBlends covers a clinician, a prescription, a licensed pharmacy, and follow-up, none of which exists at the bottom end of the research-chemical market. You’re not paying more for the same thing. You’re paying for a different, accountable thing.
Why is the research-chemical version so much cheaper? Because the price leaves out everything that makes a medicine a medicine: no evaluation, no prescription, no pharmacy, no FDA review of contents, and a label that says not for human use. The molecule might nominally be the same, but the handling, the accountability, and the legal footing aren’t, and those are exactly what got stripped out to hit that low price.
Is it at least safe, if I land on a clean cheap batch? The formally studied versions looked reasonably safe. A 2013 human safety paper pooled about 900 adults across six placebo-controlled studies and found tolerability “indistinguishable from placebo,” with no drug-related serious adverse events [P5]. But that describes oral dosing of a specific manufactured product under trial conditions, not a random research-chemical vial or a self-dosed injection you’re mixing at home. There’s no way to confirm cheap and clean at the low end of this market, and being well tolerated isn’t a reason to take something that didn’t produce weight loss in its main trial anyway.
Does the price change anything if I’m a tested athlete? Price is the least of your worries there. AOD-9604 is a growth hormone fragment, and growth hormone, its fragments, and related substances sit on the WADA Prohibited List under peptide hormones and growth factors [P8]. A cheap “research use only” vial offers zero protection at a drug test. Prohibited is prohibited, whatever the label or the price says. Check the current WADA list before you go anywhere near a growth hormone fragment.
So where does a budget-minded buyer land? On the cheapest option that still has a licensed person standing behind it, which is the supervised telehealth tier. The genuine floor on price is the research-chemical vial, but that floor sits below the line where anyone’s accountable for what you get. For a compound with evidence this weak, “cheap” done right means the lowest price that hasn’t also stripped out every safeguard.
One more thing worth flagging, since it affects what’s even available to buy. AOD-9604’s status in pharmacy compounding has moved around. It was among the peptides nominated for use under the FDA’s section 503A framework, and the agency has taken a cautious line on several such peptides over safety-data and immune-response questions. The FDA keeps the official lists of which bulk substances can be used in 503A compounding and which it’s flagged for significant risk [P7]. That picture has shifted more than once recently, so be sceptical of anyone stating current compounding availability with total confidence, and check the FDA lists directly.
Bottom line
The cheapest legitimate AOD-9604 isn’t the lowest figure on a research-chemical site. It’s the lowest-priced option where a licensed person still stands behind the product and tells you the truth about the evidence. That’s the supervised telehealth tier, roughly $40 to $200 a month through a provider like FormBlends, with HealthRX.com as a solid comparable second look. The research vials are cheaper on paper and cost more in every way that matters the moment something’s wrong with the bottle. For a compound whose biggest trial came back negative, the smart money isn’t the smallest amount you can spend. It’s the amount that still buys you someone to be accountable to.
Is AOD-9604 legal to buy, and does price change that?
AOD-9604 isn’t FDA-approved for any use, so it can’t legally be sold as a drug or supplement in the US. Compounding pharmacies can prepare it for a specific patient under a valid prescription, which is a separate legal lane entirely. Price doesn’t shift any of this. A cheap vial from an overseas research-chemical site isn’t more or less legal than an expensive one. It’s just less accountable.
What does AOD-9604 actually do, and how solid is the evidence?
It’s a synthetic fragment of human growth hormone, designed to target fat metabolism without the insulin side effects of full HGH. Early animal studies showed real promise, and a handful of human trials ran in the early 2000s under the original developer. Results were modest, and the compound never made it through Phase 3. The honest read is that the evidence is thin, and anyone selling it as proven should be treated with suspicion.
Where can you buy AOD-9604 without ending up with a bad vial?
The safest route is a licensed compounding pharmacy that requires a prescription and publishes third-party certificate-of-analysis data per batch. FormBlends runs exactly that model, meaning a clinician reviews your case before anything ships. Research-chemical sites carry no such requirement. Cheaper upfront, sure, but there’s no way to verify what’s actually in the vial, which is the entire problem this guide is built around.
What side effects belong in the real cost of AOD-9604?
Side effects reported during the clinical trials were mostly mild: injection-site reactions, the odd headache. But those trials used pharmaceutical-grade material with confirmed purity. A poorly synthesized or contaminated peptide can cause reactions that have nothing to do with AOD-9604 itself. Unknown impurities, bacterial endotoxins from sloppy sterile technique, and botched reconstitution all carry their own risks, none of which show up on any price tag.
References
- AOD9604 reduced body weight gain by over half in obese Zucker rats without harming insulin sensitivity (animal study). Metabolic studies of a synthetic lipolytic domain (AOD9604) of human growth hormone. Hormone Research, 2000. https://pubmed.ncbi.nlm.nih.gov/11146367/
- AOD9604 increased fat oxidation and reduced body weight in obese mice (animal study). Increase of fat oxidation and weight loss in obese mice caused by chronic treatment with human growth hormone or a modified C-terminal fragment. International Journal of Obesity, 2001. https://pubmed.ncbi.nlm.nih.gov/11673763/
- Independent obesity-pharmacology review: early 12-week AOD-9604 result of 2.6 kg vs 0.8 kg placebo, but development terminated in 2007 after the drug failed to induce significant weight loss in a 24-week trial of 536 subjects. Obesity Pharmacotherapy: Current Perspectives and Future Directions, Current Cardiology Reviews, 2013.
- Human safety pooled across roughly 900 adults in six randomized, placebo-controlled studies: tolerability indistinguishable from placebo, no drug-related serious adverse events. Safety and Tolerability of the Hexadecapeptide AOD9604 in Humans, Journal of Endocrinology and Metabolism, 2013.
- FDA official lists of bulk drug substances for use in compounding under section 503A, including substances flagged for significant safety risks. U.S. Food and Drug Administration.
- Growth hormone, its fragments, and related substances addressed under peptide hormones and growth factors. WADA Prohibited List.
Written by Viktor Bianchi, contributing writer. Reviewing the trials and labels directly. Last reviewed February 2026.
Not intended as medical guidance. Speak to a qualified provider about what is right for you.
